Lipid-based nanoparticles in the treatment of erectile dysfunction
Erectile dysfunction (ED) is a common disorder among men, with significant public health implications. Current therapies have certain limitations including efficacy and safety issues, necessitating the development of novel therapeutic strategies for ED. Nanotechnology-based drug delivery systems are...
Gespeichert in:
| Veröffentlicht in: | International journal of impotence research 2020-11, Vol.32 (6), p.578-586 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 586 |
|---|---|
| container_issue | 6 |
| container_start_page | 578 |
| container_title | International journal of impotence research |
| container_volume | 32 |
| creator | Güven, Eylem |
| description | Erectile dysfunction (ED) is a common disorder among men, with significant public health implications. Current therapies have certain limitations including efficacy and safety issues, necessitating the development of novel therapeutic strategies for ED. Nanotechnology-based drug delivery systems are being explored to overcome these limitations with promising in vitro and in vivo efficacies. In particular, lipid-based nanoparticles have generated considerable interest owing to their potential to enhance drug bioavailability, and decrease side effects and drug susceptibility to metabolism. This review summarizes the recent findings using lipid-based nanoparticles in ED therapy. |
| doi_str_mv | 10.1038/s41443-020-0235-7 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_gale_infotracmisc_A641015287</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A641015287</galeid><sourcerecordid>A641015287</sourcerecordid><originalsourceid>FETCH-LOGICAL-c470t-99d3990a6a023a3f9827205d256ecf35b0e9178bda867fa5d1233493b0d7f71f3</originalsourceid><addsrcrecordid>eNp1kU1rFTEUhoMo9lr9AW5kQHA37cnXZLKsRatwoRu7DpnJSW_KTOaaZBb99-Zy-2FBCSGBPO85581LyEcKZxR4f54FFYK3wKBuLlv1imyoUF0rRa9fkw1oKVutOZyQdznfAYAG2r0lJ5wBSM37Dfm6Dfvg2sFmdE20cdnbVMI4YW5CbMoOm5LQlhljaRbfYMKxhAkbd5_9Gut9ie_JG2-njB8ezlNy8_3br8sf7fb66uflxbYdhYJS53Bca7CdrbNa7nXPFAPpmOxw9FwOgJqqfnC275S30lHGudB8AKe8op6fks_Huvu0_F4xF3O3rCnWloYJRaWETvXP1K2d0ITol5LsOIc8motOUKCS9apSZ_-g6nI4h3GJ6KvJl4Ivfwl2aKeyy8u0Hj4gvwTpERzTknNCb_YpzDbdGwrmkJo5pmZqauaQmjloPj04W4cZ3ZPiMaYKsCOQ61O8xfRs_f9V_wB4NZ53</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2471550678</pqid></control><display><type>article</type><title>Lipid-based nanoparticles in the treatment of erectile dysfunction</title><source>MEDLINE</source><source>SpringerLink</source><creator>Güven, Eylem</creator><creatorcontrib>Güven, Eylem</creatorcontrib><description>Erectile dysfunction (ED) is a common disorder among men, with significant public health implications. Current therapies have certain limitations including efficacy and safety issues, necessitating the development of novel therapeutic strategies for ED. Nanotechnology-based drug delivery systems are being explored to overcome these limitations with promising in vitro and in vivo efficacies. In particular, lipid-based nanoparticles have generated considerable interest owing to their potential to enhance drug bioavailability, and decrease side effects and drug susceptibility to metabolism. This review summarizes the recent findings using lipid-based nanoparticles in ED therapy.</description><identifier>ISSN: 0955-9930</identifier><identifier>EISSN: 1476-5489</identifier><identifier>DOI: 10.1038/s41443-020-0235-7</identifier><identifier>PMID: 32005938</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/154/152 ; 692/700/565/1436/152 ; Anti-impotence agents ; Drug Delivery Systems ; Drug therapy ; Erectile dysfunction ; Erectile Dysfunction - drug therapy ; Health aspects ; Humans ; Impotence ; Lipids ; Male ; Materials ; Medicine ; Medicine & Public Health ; Nanoparticles ; Pharmacology, Experimental ; Reproductive Medicine ; Review Article ; rology ; Urology</subject><ispartof>International journal of impotence research, 2020-11, Vol.32 (6), p.578-586</ispartof><rights>The Author(s), under exclusive licence to Springer Nature Limited 2020</rights><rights>COPYRIGHT 2020 Nature Publishing Group</rights><rights>The Author(s), under exclusive licence to Springer Nature Limited 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c470t-99d3990a6a023a3f9827205d256ecf35b0e9178bda867fa5d1233493b0d7f71f3</citedby><cites>FETCH-LOGICAL-c470t-99d3990a6a023a3f9827205d256ecf35b0e9178bda867fa5d1233493b0d7f71f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/s41443-020-0235-7$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/s41443-020-0235-7$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32005938$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Güven, Eylem</creatorcontrib><title>Lipid-based nanoparticles in the treatment of erectile dysfunction</title><title>International journal of impotence research</title><addtitle>Int J Impot Res</addtitle><addtitle>Int J Impot Res</addtitle><description>Erectile dysfunction (ED) is a common disorder among men, with significant public health implications. Current therapies have certain limitations including efficacy and safety issues, necessitating the development of novel therapeutic strategies for ED. Nanotechnology-based drug delivery systems are being explored to overcome these limitations with promising in vitro and in vivo efficacies. In particular, lipid-based nanoparticles have generated considerable interest owing to their potential to enhance drug bioavailability, and decrease side effects and drug susceptibility to metabolism. This review summarizes the recent findings using lipid-based nanoparticles in ED therapy.</description><subject>631/154/152</subject><subject>692/700/565/1436/152</subject><subject>Anti-impotence agents</subject><subject>Drug Delivery Systems</subject><subject>Drug therapy</subject><subject>Erectile dysfunction</subject><subject>Erectile Dysfunction - drug therapy</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Impotence</subject><subject>Lipids</subject><subject>Male</subject><subject>Materials</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Nanoparticles</subject><subject>Pharmacology, Experimental</subject><subject>Reproductive Medicine</subject><subject>Review Article</subject><subject>rology</subject><subject>Urology</subject><issn>0955-9930</issn><issn>1476-5489</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kU1rFTEUhoMo9lr9AW5kQHA37cnXZLKsRatwoRu7DpnJSW_KTOaaZBb99-Zy-2FBCSGBPO85581LyEcKZxR4f54FFYK3wKBuLlv1imyoUF0rRa9fkw1oKVutOZyQdznfAYAG2r0lJ5wBSM37Dfm6Dfvg2sFmdE20cdnbVMI4YW5CbMoOm5LQlhljaRbfYMKxhAkbd5_9Gut9ie_JG2-njB8ezlNy8_3br8sf7fb66uflxbYdhYJS53Bca7CdrbNa7nXPFAPpmOxw9FwOgJqqfnC275S30lHGudB8AKe8op6fks_Huvu0_F4xF3O3rCnWloYJRaWETvXP1K2d0ITol5LsOIc8motOUKCS9apSZ_-g6nI4h3GJ6KvJl4Ivfwl2aKeyy8u0Hj4gvwTpERzTknNCb_YpzDbdGwrmkJo5pmZqauaQmjloPj04W4cZ3ZPiMaYKsCOQ61O8xfRs_f9V_wB4NZ53</recordid><startdate>20201101</startdate><enddate>20201101</enddate><creator>Güven, Eylem</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20201101</creationdate><title>Lipid-based nanoparticles in the treatment of erectile dysfunction</title><author>Güven, Eylem</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c470t-99d3990a6a023a3f9827205d256ecf35b0e9178bda867fa5d1233493b0d7f71f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>631/154/152</topic><topic>692/700/565/1436/152</topic><topic>Anti-impotence agents</topic><topic>Drug Delivery Systems</topic><topic>Drug therapy</topic><topic>Erectile dysfunction</topic><topic>Erectile Dysfunction - drug therapy</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Impotence</topic><topic>Lipids</topic><topic>Male</topic><topic>Materials</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Nanoparticles</topic><topic>Pharmacology, Experimental</topic><topic>Reproductive Medicine</topic><topic>Review Article</topic><topic>rology</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Güven, Eylem</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest_Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>International journal of impotence research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Güven, Eylem</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lipid-based nanoparticles in the treatment of erectile dysfunction</atitle><jtitle>International journal of impotence research</jtitle><stitle>Int J Impot Res</stitle><addtitle>Int J Impot Res</addtitle><date>2020-11-01</date><risdate>2020</risdate><volume>32</volume><issue>6</issue><spage>578</spage><epage>586</epage><pages>578-586</pages><issn>0955-9930</issn><eissn>1476-5489</eissn><abstract>Erectile dysfunction (ED) is a common disorder among men, with significant public health implications. Current therapies have certain limitations including efficacy and safety issues, necessitating the development of novel therapeutic strategies for ED. Nanotechnology-based drug delivery systems are being explored to overcome these limitations with promising in vitro and in vivo efficacies. In particular, lipid-based nanoparticles have generated considerable interest owing to their potential to enhance drug bioavailability, and decrease side effects and drug susceptibility to metabolism. This review summarizes the recent findings using lipid-based nanoparticles in ED therapy.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>32005938</pmid><doi>10.1038/s41443-020-0235-7</doi><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0955-9930 |
| ispartof | International journal of impotence research, 2020-11, Vol.32 (6), p.578-586 |
| issn | 0955-9930 1476-5489 |
| language | eng |
| recordid | cdi_gale_infotracmisc_A641015287 |
| source | MEDLINE; SpringerLink |
| subjects | 631/154/152 692/700/565/1436/152 Anti-impotence agents Drug Delivery Systems Drug therapy Erectile dysfunction Erectile Dysfunction - drug therapy Health aspects Humans Impotence Lipids Male Materials Medicine Medicine & Public Health Nanoparticles Pharmacology, Experimental Reproductive Medicine Review Article rology Urology |
| title | Lipid-based nanoparticles in the treatment of erectile dysfunction |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T14%3A37%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lipid-based%20nanoparticles%20in%20the%20treatment%20of%20erectile%20dysfunction&rft.jtitle=International%20journal%20of%20impotence%20research&rft.au=G%C3%BCven,%20Eylem&rft.date=2020-11-01&rft.volume=32&rft.issue=6&rft.spage=578&rft.epage=586&rft.pages=578-586&rft.issn=0955-9930&rft.eissn=1476-5489&rft_id=info:doi/10.1038/s41443-020-0235-7&rft_dat=%3Cgale_proqu%3EA641015287%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2471550678&rft_id=info:pmid/32005938&rft_galeid=A641015287&rfr_iscdi=true |